Increasing Use of Compassionate Use/Managed Access Channels to Obtain Medicines for Use in COVID-19.

Aliu, Paul; Sarp, Séverine; Fitzsimmons, Paige

Aliu, Paul; Sarp, Séverine; Fitzsimmons, Paige.

Aliu P; Chief Medical Office, Novartis Pharma AG, Basel, Switzerland.
Sarp S; Chief Medical Office, Novartis Pharma AG, Basel, Switzerland.
Fitzsimmons P; GE2P2 Global Foundation, Philadelphia, Pennsylvania, USA.

Clin Pharmacol Ther ; 110(1): 26-28, 2021 Jul.

Article in English | MEDLINE | ID: covidwho-978126

Subject(s)

COVID-19 Drug Treatment; COVID-19; Compassionate Use Trials; Drug Repositioning/methods; Drug and Narcotic Control; Drugs, Investigational; Health Services Accessibility; COVID-19/epidemiology; Compassionate Use Trials/ethics; Compassionate Use Trials/methods; Compassionate Use Trials/standards; Drug Approval/methods; Drug and Narcotic Control/organization & administration; Drug and Narcotic Control/trends; Drugs, Investigational/supply & distribution; Drugs, Investigational/therapeutic use; Emergency Medical Services/ethics; Emergency Medical Services/methods; Health Services Accessibility/organization & administration; Health Services Accessibility/trends; Humans; Internationality; Physician's Role; Risk Assessment; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drugs, Investigational / Drug and Narcotic Control / Compassionate Use Trials / Drug Repositioning / COVID-19 / COVID-19 Drug Treatment / Health Services Accessibility Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Clin Pharmacol Ther Year: 2021 Document Type: Article Affiliation country: Cpt.2140

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google